logo
Select company
Select metric
2.26%Return on Equity
VS
Market
47
Sector
81
Industry
91
History
100
$ 11.1Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information

Ticker

ZVRA

Company Name

ZEVRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZEVRA THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZVRA - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 117.23M$ 2.64M2.26%
3/31/2025$ 41.02M$ -91.99M-224.24%
12/31/2024$ 39.67M$ -105.51M-266%
9/30/2024$ 69.77M$ -84.92M-121.72%
6/30/2024$ 32.48M$ -65.75M-202.43%
3/31/2024$ 48.82M$ -50.9M-104.27%
12/31/2023$ 61.86M$ -46.05M-74.44%
9/30/2023$ 67.47M$ -39.92M-59.16%
6/30/2023$ 68.5M$ -32.49M-47.43%
3/31/2023$ 71.4M$ -51.45M-72.05%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, ZEVRA THERAPEUTICS INC's average ROE has been -84.15%.
  • The median ROE for ZEVRA THERAPEUTICS INC during this period was -54.95%
  • ZEVRA THERAPEUTICS INC reached its highest ROE over the past 5 years at 2.26%.
  • The lowest ROE recorded by ZEVRA THERAPEUTICS INC in the same timeframe -266%

ZEVRA THERAPEUTICS INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
EYPT : EYEPOINT PHARMACEUTICALS INC -71.29%TBPH : THERAVANCE BIOPHARMA INC 5.8%SAGE : SAGE THERAPEUTICS INC -81.68%MGTX : MEIRAGTX HOLDINGS PLC -5321.11%LXRX : LEXICON PHARMACEUTICALS INC -93.19%NKTR : NEKTAR THERAPEUTICS -KURA : KURA ONCOLOGY INC -64.54%GOSS : GOSSAMER BIO INC -NRIX : NURIX THERAPEUTICS INC -65.76%SNDX : SYNDAX PHARMACEUTICALS INC -212.79%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for ZEVRA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -13.94M ] / Equity [ $ -62.33M ]
(=) ROE [ 0% ]

ZVRA - Return on Equity, Last 5 years

-266%

Minimum

Dec 31, 2024

2.26%

Maximum

Jun 30, 2025

-84.15%

Average

-54.95%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.52% with a standard deviation of 22.72%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.49%
average1.52%
median6.45%
std22.72%